Infectious Diseases (except HIV/AIDS)
-
Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data
This article has 6 authors:Reviewed by ScreenIT
-
Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer
This article has 8 authors:Reviewed by ScreenIT
-
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study
This article has 14 authors:Reviewed by ScreenIT
-
Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US
This article has 8 authors:Reviewed by ScreenIT
-
Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
This article has 13 authors:Reviewed by ScreenIT
-
Breakthrough SARS – CoV ‐2 Infections in Patients With Immune‐Mediated Disease Undergoing B Cell–Depleting Therapy: A Retrospective Cohort Analysis
This article has 7 authors:Reviewed by ScreenIT
-
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study
This article has 13 authors:Reviewed by ScreenIT
-
A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy
This article has 19 authors:Reviewed by ScreenIT
-
Childhood Trauma Exposure Increases Long COVID Risk
This article has 6 authors:Reviewed by ScreenIT
-
Carbapenem-resistant Klebsiella pneumoniae in university-affiliated hospitals: risk factors for isolation among hospitalized patients and molecular subtyping
This article has 4 authors:Reviewed by PeerRef